AVD

Business Context and Reporting Period

Company: American Vanguard Corp (AMVAC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Business Overview: The Company manufactures and markets crop protection products (insecticides, herbicides, fungicides) and non-crop products. The first quarter of 2011 was characterized by favorable market conditions, particularly in the crop sector, driven by channel restocking and increased acreage for crops like cotton and peanuts.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 44% year-over-year. Crop sales rose 58% (driven by a 140% increase in insecticides due to 2010 acquisitions and strong demand), while non-crop sales declined 10%.
• Profitability: Net income nearly tripled to $5.0 million. Operating income increased 142% to $9.2 million, aided by improved gross margins (42% vs 41%) and higher sales volume.
• Debt Restructuring: On January 10, 2011, the Company entered a new $137 million credit facility, replacing the previous $135 million facility. This resulted in a one-time charge of $546,000 for debt extinguishment.
• Working Capital: Accounts receivable increased significantly by $29.9 million due to higher sales volume. Inventory increased by $3.2 million. Deferred revenue decreased by $5.5 million as prior year accruals were realized.
• Operating Expenses: Increased by $4.0 million, primarily due to higher advertising, bonus provisions, amortization of acquired intangibles, and stock-based compensation.

Guidance, Outlook, Risks, and Unusual Items

• Regulatory Risks (PCNB): The Company faces significant uncertainty regarding its PCNB product line. The Canadian PMRA cancelled turf registrations, and the US EPA issued a Stop Sale, Use, and Removal Order (SSURO) citing formula non-compliance. The Company holds $18.1 million in PCNB inventory and $5.2 million in related intangibles. A loss contingency of $500,000 has been recorded for Canadian inventory, but no contingency is set for US assets as the outcome is uncertain.
• Legal Proceedings:
  • DBCP Litigation: Approximately 100 lawsuits remain pending regarding exposure to the chemical DBCP. The Company does not believe a loss is probable or estimable.
  • Brazilian Citation: A potential fine of $200,000 regarding product color discrepancies; a $150,000 loss contingency has been recorded.
  • Superfund: A settlement of approximately $50,000 has been reached for the Archem Superfund action.
• Liquidity: Despite negative operating cash flow, the Company has significant borrowing capacity. Under the new credit facility, the Company had the capacity to increase borrowings by up to $69.9 million as of March 31, 2011.
• Unusual Items: The $546,000 debt extinguishment charge and the $6.8 million non-cash addition to intangible assets related to purchase accounting adjustments for 2010 acquisitions.

Investor Verification Checklist

• PCNB Resolution: Monitor the status of the USEPA SSURO and Canadian PMRA cancellation, as the outcome could require a write-down of $23.2 million in assets (inventory + intangibles).
• Debt Covenants: Verify continued compliance with the new credit facility covenants, specifically the modified current ratio and fixed charge coverage ratio.
• Seasonality: Assess whether Q1 sales growth (driven by channel restocking) is sustainable or if it front-loads the fiscal year.
• Acquisition Integration: Review the performance of product lines acquired in late 2010 (Aztec, Mocap, Nemacur) to ensure they meet projected revenue targets.
• DBCP Litigation: Track developments in the DBCP lawsuits, particularly the pending appeal in the Patrickson case, for potential future liability.